Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014 - 2020

Published: May, 2016 | Pages: 596 | Publisher: Axis Research Mind
Industry: Healthcare | Report Format: Electronic (PDF)

Global Market Watch:

Human Biobanking market is expected to reach US$37.1 billion 2020 primarily supported by application; Stem Cells, Blood and Blood Products, Research and Pharmaceuticals…etc. Among the Human Biobanking Application market, Advance Application is the fastest growing market with a CAGR of 9.65%. Organs and Research application in human banking together accounts approximately for 24% of the market share. Stem Cells, Blood and Blood Products, Research market with a positive growth rate during the period. Human Biobanking Industry is playing an increasing role in development of therapies and diagnosis of diseases with well-maintained researchers and institutions.

Report Focus:

The report “Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

- Emerging market trends
- Advancements in the technological space
- Market demand of the segments (by-region)
- Key growth areas and market size
- Key competitor’s Edge

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with human biobanking applications market. Further, the subdivided categories include:

- Blood1& Blood Products
- Organs
- Advanced Applications
- Biomarkers
- Genomics
- Drug Discovery
- Forensics
- ResearchStem Cells
- Pharmaceuticals
- Other

1. Red Blood Cells, Plasma and Platelets
2. Tissue Sections, Liver, Eyes, Kidney, Brain, Heart and Other
3. DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.
4. Body Fluids (Synovial, Urine, Sputum, Buccal Scrapings and Sperm), Contract Services and Process Chemicals

The period considered for the human biobanking applications market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia- Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 157 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

List of Key Companies

North America

- Vericel Corporation
- Acorda Therapeutics, Inc.
- Alpha Cord, Inc.
- Affymetrix, Inc.
- Cellerant Therapeutics, Inc.
- Cryo-Cell International, Inc.
- Mesoblast, Inc.
- Atgc Labs
- Autogen, Inc.
- Barber Nichols
- Beckman Coulter, Inc.
- Biocision
- U.S. Stem Cell, Inc.
- Biolife Solutions, Inc.
- Biological Specimen Inventory System
- Biomatrica, Inc.
- Biostorage, Llc.
- Cti Biopharma Corp.
- Chart Industries, Inc.
- Charter Medical, Ltd.
- Corcell, Inc.
- Cord Blood Registry
- Core Dynamics (Usa), Inc.
- Cryolife, Inc.
- Cryomagnetics, Inc.
- Cryoplus, Inc.
- Cryoxtract
- Custom Biogenic Systems
- Dataworks Development, Inc.
- Dna Genotek, Inc.
- Epl Archieves, Inc.
- Genzyme Corp.
- Gilead Sciences, Inc.
- Hamilton Storage Technologies
- Labvantage Solutions, Inc.
- Labware, Inc.
- Lifenet Health
- Caladrius Biosciences, Inc.
- Eppendorf, Inc.
- Novare Biologistics
- Origen Biomedical, Inc.
- Osiris Therapeutics, Inc.
- Pacific Bio-Material Management, Inc.
- Promeddx, Llc
- Provia Laboratories, Llc
- Qiagen Nv
- Rand Corporation
- Ruro
- Seracare Life Sciences
- Scientific Instruments, Inc.
- Sp Scientific
- Spectrocell, Inc.
- Abbott Laboratories
- Steelgate, Inc.
- Trillium Therapeutics, Inc.
- Stem Cells, Inc.
- Stemcell Technologies, Inc.
- Lifeline® Cell Technology
- Thermo Fisher Scientific, Inc.
- Cesca Therapeutics, Inc.
- Trans-Hit Biomarkers, Inc.
- Vaisala, Inc.
- Viacord
- Vital Therapies, Inc.
- Wheaton Science Products, Inc.

Europe

- Panasonic Biomedical Sales Europe B.V
- Epistem Ltd.
- Aqix
- B & C Group
- Bbmri
- Lifegene
- Biobank Ireland Trust
- Biokryo Gmbh
- Biorep Srl P.Iva
- Biostorage Technologies, Inc.
- Boehringer Ingelheim, Gmbh
- Cells4life, Ltd.
- Cryo Bio System
- Cryo-Save, Ag
- Decode Genetics
- Ge Healthcare Life Sciences
- Genesisbps
- Highres Biosolutions
- Indivumed
- Lifegene Biobank
- Lifelines Cohort and Biobank (Lifelines)
- Linde Gas Cryoservices B.V.
- Modul-Bio Sas
- Mts Cryostores Uk Ltd
- Noray Bioinformatics S.L.U.
- Reneuron Group Plc
- Sanofi Aventis
- Soventec Gmbh
- Stirling Cryogenics & Refrigeration Bv
- Tecan
- Tissue Solutions
- Uk Stem Cell Bank

Asia-Pacific

- Cole Parmer Instrument, Co.
- Cordlife Pte., Ltd.
- Cryocord Sdn. Bhd.
- Cryologic Pty. Ltd.
- Genesearch
- Ocimum Biosolutions
- Reliance Life Sciences
- China Cord Blood Corporation

Rest Of World

- Babycell Egypt
- Gamida Cell Ltd.

 
Table of Contents
  I. Report Focus
A. Introduction
  Biorepository
  Classifying Biobanks
  Storing Samples in A Biobank
  Biospecimen Security and Storage
The Generational Evolution Of Biobank
  Putting Together A Bio Bank With Its Requirements and Capacities
  Technical Requirements
  Functional Requirements
Biorepository Operations
  Getting A Biorepository Accredited
  The Role Of Synthetic Data in Biobank Analysis
B. Biobanking Benefits
  Conclusion
C. Biospecimens (Collection, Processing, Storage, Retrieval and Disseminate) Biospecimens in Cancer Research
  Biospecimens - The Legacy Plan
  Decades Old Specimens May Be Today’s Research Treasures
Biospecimen Management System
  The Modern Approach To Biobanking
  Isolating Stomach-Cell Populations Using Lcm
  Results From The Bpv Program
  Evaluation Of Pre-Analytical Factors on Identification
  Of Copy Number Variations
  The Impact Of Ex-Vivo Ischemia Time on Quality Of Rna
  The Ideal Physical Environment For Biospecimens
  Case Study: Advanced It System For Research Biorepository
  Physical Phenomenon At Low Temperatures
  Biological Phenomenon At Low Temperatures
  Storage Methods For Various Biospecimens
  1. Storing Proteins and Purified Nucleic Acids
  2. Storing Cryo-Preserved Cells
  3. Storing Tissues
Conclusion
Transporting Biospecimens
Effects Of Transportation on Mononuclear Cells
  Finding Bio-Samples
  Out Of The Cold-Dry State
  Banking on Success For Precision Medicine
  The Close Of The Ultimate Period in Bio-Banking
  Cost Of Value Study: Relate The Theory To Biobanks
Malfunction Costs:
External Stoppage Costs:
  Biobank Economic Modeling Tool: A Cost Improvement Device For Continuity Of Bio-Banks
  Institution Of An Iso15189 Accredited Bio-Bank For Global Clinical Research Studies
  Critical Moves To Build Bio-Banks: Stage Wise Process For Low Income Nations
  The Institution Of A Bio-Bank and Cohort Network (Bcnet) For Low and Middle Income Countries
  Bio-Banking and Translational Medicine: The Scholarly Outlook
  A Workable Methodology Devised By Bio-Bank Graz: A Representation For Other University-Based Institutions
  The Sustainability Issue Of A Community Hospital-Based Bio-Bank and Core Molecular Laboratory: The Beaumont Understanding
  To Maintain A Disease Centered Bio-Banking - An Active Approach
D. Biobanking Principles
  Norms Based on Interface Comprehension
  Data Standards Are Not Maximized in Research Bio-Banking
  Data Standards - Proposed By Obbr and Isber
  Data Standards Program For Bio-Banks
  Design Of A Registry Of Standard Operating Protocols For Tissue Compilation
E. Path Breaking Technologies
  The Bio-Bank Information Management System Life Cycle Organization and The Bims Cloud Management Platform
  Amalgamation Of Standard Pre-Analytical Code With Bio-Bank Organization Software Freezer Pro
  Evaluation Of Computerization Technologies and Physical Storage and Recovery
  Future Outlook and Concerns in The Setup Of Software Solutions in An Interdisciplinary Clinical Biobank
  A Mechanical Laboratory Workflow For Stool Dna Removal
  Consistent Workflow For Bio-Material Appeals
  Partially Computerized Bio-Bank Sample Processing With A 384 High Density Sample Tube Robot Deployed in Cancer and Cardiovascular Research
  An Autonomous Appraisal Of The Cryoxtract Cxt350 Frozen Bio-Specimen Coring Application With Tissue and Stool Fecal Samples
  Heat Standardization Of Tissue Samples Supports Measurement Without Intrusion From Post-Mortem Occurrences and Permits For Refinement Because Of Minimized Intra Group Variability
  Biot Cryocarrier - Standardized Cryogenic Temperature Handling Of Biospecimens
  Protection By Vaporization For Bio-Banking
  Optimum Specimen Security With Complete Automation Characteristics: The Automated Ln2 Vapour Phase Freezer
  Exercise Of Electronic P-Chips in A Mono and Duotagging System For Sample Tubes Used in Bio-Banking
  Sample Trail and Prerequisite With Iplex® Pro Sample Id
  Usage Of An E-Consent System For Bio-Bank Patient Consent – The Three Whys
  Cell Line Verification With The Use Of Snp Trace™ Panel: A High-Throughput, Affordable Snpbased Interface For Fingerprinting, Identifying Infectivity, and Establish Origin Of Derivative Cell Lines
  Next-Generation Dna Sequencing With Sustained Preserved Serum Samples
  An Assessment Of Frozen Aliquotting Application For The Stabilization Of Small Molecule and Peptides in Bio-Analytical Technology
  F. Biobanking Performances
  Performances Inside The Bio-Bank
  Ethical, Legal and Appropriate Strategies
  Societal Commitment For Growth Of Cdc Policy Leading Supervision Of Specimens Attained From American Indian/Alaska Native People
  Legal and Regulatory Hurdles That Impact Completion Of An Inter-Institutional Bio-Bank System
  In –Depth Appraisal on Bio-Banking Performances
  Specimen Research
  Safeguard and Control Sample Data
  Bio-Samples Preservation and Safety Precautions
  Monitor Samples Through Transport
  Farm Out Samples
  Conclusion
G. Biobank Applications
Stem Cells
  Fundamental Features in Setting Up A Stem Cell-Specific Bank
  Safeguards To Future Health Via Cord Blood and Cord Tissue Stem Cells
  Safeguard Ones Health For Years To Come
Blood and Its Components
  Red Blood Corpuscles
  Plasma
  Blood Platelets
  Types Of Biobanks
Organ and Tissue Biobank For Therapy and Transplantation
  Genetic Biobanks
  Population Biobank
  Some Common Objectives Of Biobanks:
  Therapy For The Most Prevalent Genetic Disorders
Pharmaceuticals
  Customized Drugs
  Expansion Of Novel Drugs
Research
  Stem Cells
  A Biobank’s Impact: Achieving Translation Medicine in Cancer Research
  Effects Of A Biobank on Clinical Research
  Biobank Investigations Advantages
H. Biobank - Advanced Applications
  Current Role Of Bio-Banking in Medical Environment
  A Case For Outsourcing
  A Biomaterial Storage Provider
  Cold-Chain Management, Tracking and Monitoring
  Brain Bank
Extracting A Brain
Fixation Alternatives For Rna Preservation
  Comparison Of The Fluidigm Snp Trace™ Panel and Dnaqual
  The Connection Between Cardiac Transplantation and Biobanks
  Gentype-Tissue Expression
  Factors Affecting Storage Of Biological Tissues
  Long-Term Storage Of Dna: Old and New Methods
Conclusion
I. Cancer Biobanking
  The Role Of Biobanks in Cancer Research
Biobanks: The Benchmarks
  Case Study: Janus Serum Bank
  Informed Consent Amongst Disadvantaged Communities
  For Biobank Research
  Enhancing Collection Methods At The Uccitb
  The Role Of The Ccgc in Cancer Research in China
  The Pcbn:
Prostate Cancer
  Overview
  Prostate Cancer Biobanking: Collection Methods and Evaluation Techniques
  A Prostate Cancer Biorepository To Satisfy International Collaborative Demands
  Procure Prostate Cancer Biobank
  Mirror Image Method: A New Technique For Histological Assessment Of Tumor Samples
  New Consenting Programs in The Wcb
  Next-Generation Cancer Biobanking: Sequencing and Personalized Medicine
  What Are Sustainability Metrics in A Cancer-Oriented Biobank?
  Estimating Biobank Inventory Requirements
  Platforms To Screen New Cancer-Inhibiting Drugs
  The Development Of New Techniques To Perform Downstream Analysis Of Immuno-Stained Ffpe Slides
A Biobank’s Economic Drivers
  The Role Of Standardized Procedures in Biobank Management Decreasing Research Costs
  Enhancing Patient Care At Lower Costs
Biobanks and Cancer Evolution
  Biobank Trends
Biomarkers
  The Relation Between Biomarkers and Biobanks
  Maximizing Chances Of Biomarker Identification
  The Effect Of Pre-Analytical Variables on Tissues
  Examples Of Biomarker Identification
  Immune Cells As Biomarkers For Exposure To Ionizing Radiation:
  Frozen Tissue-Core Analysis
  Storage Stability Of Cytokine Diabetes Biomarkers
Forensics
  Drug Breakthroughs
  J. Human Biobanking Applications - Geography Market Briefing
  North America
  Europe
  Asia-Pacific
  Rest Of World
K. Human Biobanking Advanced Applications - Geography Market Briefing
  North America
  Europe
  Asia-Pacific
  Rest Of World
II. Market Analysis
  Human Biobanking Application - Global
  Human Biobanking Application – By Geography
  North America
  Europe
  Asia-Pacific
  Rest Of World
Human Biobanking - By Applications Type
  Human Biobanking Application - Type - By Geography
  Stem Cells
  North America
  Europe
  Asia-Pacific
  Rest Of World
Advanced Application
  North America
  Europe
  Asia-Pacific
  Rest Of World
Advanced Application - By Type
  Advanced Application – Type – By Geography
  Biomarkers
  North America
  Europe
  Asia-Pacific
  Rest Of World
Drug Discovery
  North America
  Europe
  Asia-Pacific
  Rest Of World
Genomics
  North America
  Europe
  Asia-Pacific
  Rest Of World
Forensics
  North America
  Europe
  Asia-Pacific
  Rest Of World
Blood and Blood Products
  North America
  Europe
  Asia-Pacific
  Rest Of World
Organs
  North America
  Europe
  Asia-Pacific
  Rest Of World
Research
  North America
  Europe
  Asia-Pacific
  Rest Of World
Pharmaceuticals
  North America
  Europe
  Asia-Pacific
  Rest Of World
Other Human Biobanking Application
  North America
  Europe
  Asia-Pacific
  Rest Of World
B. Growth Rate Analysis
  Global Human Biobanking Application - Market Growth Rates
  Human Biobanking Application Market - Type
  Global Human Biobanking Application – Type Growth Rates
Human Biobanking Advance Application Market - Type
  Global Human Biobanking Advance Application - Type - Growth Rates
C. Investment Focus
III. Industry Overview
  A. Biobanking - Geographical Distribution in Detail
  Biobanking in The Americas
  Canada
  To Assess The Scale and Limitations Of Industry Access To Publicly-Financed Biobanks in Canada
  The Canadian Longitudinal Study on Aging: Biorepository Functions and Networks
Brazil
  Outcomes To Give To Contributors: A Debate in Brazil
USA
  Status on The Development and Growth Of A Combined System Of Repositories At The University Of Iowa
Biobanking in Europe
  Consolidation on Present Advantages
  European Biobanks Are Crucial Resources Assets For The Distribution Of Individualized Medicine
  Cohorts As A Potential Instrument To Know Personalized Distinction
  Ethical, Legal and Social Issues (Elsi)
  Priority Issues For Personalized Medicine Within Europe
  Biobanking and Biomolecular Resources Investigate Communications - European Research Infrastructure Consortium
  Future Entry in To Bigger European Cohorts Via Transnational Biobanking Infrastructure Bbmri-Lpc
  9 Years Relating Swiss Biobanks – En Route To A Swiss Biobanking Policy
Germany
  Constant and Maintainance and Support Of Biobank-Based Medical Research: A Decade Of Experience in Germany
Austria
United Kingdom
  Combined Effective Network Of Biobanks
Italy
  Biobanks and Ethical Concerns in Italy
Other European Countries
  Strategy Development For Emerging Biobanks on The Example Of Kosovo and Albania
Biobanking in Asia-Pacific
  Japan
  Evaluation Of Id Integrity With Abo Blood Typing-Questionnaire To Genomic Data in Japanese Biobank
  Assessment Of Cell-Type Composition in Peripheral Blood Mononuclear Cells Enhances Value Of Omics Data in Biobank Research
South Korea
  Current Trends in Korea Gynecologic Cancer Bank
  Ebiobanking System For Korea Gynecologic Cancer Bank
China
  Achievements
  Biobanking For The Born in Guangzhou Cohort Study: An Innovative Resource For Maternal and Child Health Research in China
Aims
Advantages
  Construction Of Shanghai Cancer Biobank Stage For Research
India
  Objectives
  Goals
  Areas
  Principles
  The Age Bio-Banking in India
  To Create A Disease-Linked Reliable Biobank in India
  Moral Concerns in Biobanking: Stepping Up The Program in India
  Biobanking Is A Promising Proposition in India-Factors
  I. Ethical Concerns With Regard To Biobanking
  People’s Perspective Towards Biobanking Research
  Acceptance By Contributors in Biobanking Research
Consent Types
  Removal Of Consent/Obliteration Of Bio-Samples
  Chief Causes For Pull Out
Privacy and Secrecy
  II. Ethical Issues Linked To Research Procedures
  Storage Of Samples
  Derived Or Extensive Uses Of Stored Samples
  Relocation Of Samples and Information
III. Conclusion
  First Biobank By 2016 in Eastern India
Australia
  Australian Prostate Cancer Bio-Resource, 2015
  Enhancing Bio-Samples Quality Inside The Banking System: An Australian Outlook
Biobanking in Rest Of World
  The Consequences Of Mini-Biobank in Hazardous Climates in Iraq
  Biodiversity/Environmental Microbial Storehouse System in Emerging Nations-Spotlight on Nigeria
  The Progress Of The National Biobanking Industry For Preservation Of South African Biodiversity
  Qatar Biobank: Public Health Concerns Reported
  Biobanking Initiative in Saudi Arabia: The Cegmr Biobank Know-How
B. A Review on Bio “Banks”
  Relevance Of Biobanks in Scientific Research
C. Major Prospects For Biorepositories in The Future
  The Key Impact Of Biorepositories in Its Applications
Biggest Challenges and Opportunities in Biorepositories
  Biobanks Will Be Challenged By Increasing Financial Pressures
  Biggest Opportunities
  Present Challenges Of Biobanking: Bioethical and Property Issues
  Added Value Of Biobanks For Health: An Evolutionary Perspective
Future Challenges
Conclusions
D. Industry Activities
  Mergers/Acquisitions/Agreements/Patents Grants/Joint Ventures/Innovations/Product Launches/Etc……
  Cesca Therapeutics Enters Into Collaborative Agreement With Center For Immune Cell Therapies At Memorial Sloan Kettering Cancer Center
  Agilent Technologies To Acquire Seahorse Bioscience, Industry Leader in Tools For Measuring Cell Metabolism
  International Stem Cell Corporation Announces Next Phase Of Research Collaboration With Rohto Pharmaceutical Co., Ltd. Of Japan
  Partners Get $12.3m To Advance Genomic Medicine
  New Study Demonstrates Absence Of Extractable Organic Contaminants in Micronic’s Polypropylene Sample Storage Tubes
  Valeant Pharmaceuticals To Acquire Synergetics USA
  Sysmex Receives In-Vitro Diagnostic Approval For Manufacturing and Sales Of Three Platelet Aggregation Agonist Reagent Kits
  Amag Pharmaceuticals Completes Acquisition Of Cord Blood Registry
  Biotek Synergy™ Neo2 Granted Cisbio Htrf® Certification
  Avita Medical Announces New Research Partnership With University Of Huddersfield
  Stemcell Technologies Inc. Enters A Licensing Agreement With Ips Academia Japan, Inc. For Induced Pluripotent Stem Cell Research Technologies
  Immatics and Md Anderson Announce Launch Of Immatics Us, Inc., To Develop Multiple T-Cell and Tcr-Based Adoptive Cellular Therapies
  Bio-Rad Introduces The Ih-500, A Fully Automated Random Access System For Blood Typing and Screening
  Groundbreaking Clinical Trial To Assess Use Of Newborn Stem Cells in The Treatment Of Pediatric Stroke
  Genotyping Begins on Nida’s Biorepository Of Over 50,000 Samples – Affymetrix, Biorealm and Rucdr Infinite Biologics Team Up To Help Study The Genetics Of Addiction
  Stem Cells - Promising Options For Alternative Medical Therapeutic Approaches
  Celgene Handed $1 Billion To Small Biotech Developer Juno Therapeutics
  Medimmune Partners With The University Of Sheffield To Generate Innovations in Cell Factory Engineering Science
  Cytox and Affymetrix Form Strategic Partnership To Develop and Commercialize Blood-Based Genetic Assay For Alzheimer’s Disease Risk Assessment
  Genotyping Begins on Nida’s Biorepository Of Over 50,000 Samples – Affymetrix, Biorealm, and Rucdr Infinite Biologics Team Up To Help Study The Genetics Of Addiction
  Mount Sinai Medical Center Selects Stemsoft Clinic
  Integra Lifesciences Completes Acquisition Of Tei Biosciences and Tei Medical
  Bloodcenter Launches Gene Deletion/Duplication Analysis
  Cryoport Provides Cryogenic Logistics Solutions To Hemacare Corporation
  Biomatrica, Inc. Announces Release Of Dnagard® Saliva Ht, Saliva Dna Collection
  Seracare Life Sciences Announces Strategic Partnership With Vivebio To Enable
  Lake Shore Exhibiting Cryogenic Monitoring and Control Solutions At Cec/Icmc
  Cryolife Receives Expanded Indication For Bioglue® in Japan
  Dna Genotek Inc. Receives Ce-Ivd Mark For Its Omnigene®•Gut Microbiome Collection Kit
  Debiopharm International Sa Acquires Fibrotrap Sample Processing Technology From Spinomix
  Sysmex and Labcorp Announce A Strategic Collaboration For Blood-Based Molecular Testing Services and Products To Support The Development Of Precision Medicine in Oncology
  Reneuron Group Plc S Research Collaboration With Benitec Biopharma
  Stemcell Technologies Launches Innovative Products To Support Car T Cell Research
  Ultra Low Binding Tubes For Proteomics
  Caladrius Biosciences, Inc. Finalizes Corporate Name Change From Neostem, Inc.
  Stemgent, A Reprocell Group Company Launches A New High Performance Self-Replicative Rna Reprogramming Kit
  Takara Bio Europe Releases An Innovative Ips Cell Culture Medium For Pre-Clinical Use: Cellartis® Def-Cs™ Xeno-Free Culture Medium Göteborg, Sweden
  Octane and Lonza Announce Exclusive Collaboration To Evaluate Groundbreaking Autologous Cell Therapy Technology
  Axt To Distribute Openspecimen Biobanking Software Solution
  Nikon and Lonza Form Collaboration For Cell and Gene Therapy Manufacturing in Japan
  Dna Genotek Inc. Launches Microbial Dna Self-Collection Kit-Omnigene®•Gut Product Optimizes Samples For Microbiome Analysis
  Biocision and Brooks Automation Announce Industry's First Portable Cryogenic Biospecimen Transport System With Integrated Real-Time Temperature Monitoring
  Cryo-Cell’s New Cord Blood Processing Method Enables Parents To Obtain Better Cord Blood Units For Their Babies
  Avita Medical Announces Issuance Of A New U.S. Patent For Recell®
  Titian Software Expands Offering With New Mosaic Freezer Management
  Alliqua Biomedical Announces Expansion To Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics
  Secure Automated Cryogenic Storage
  Lonza, The World’s Leading Developer and Manufacturer Of Cells For Regenerative Medicine Therapeutics, and Nikon Corporation Announced Today An Exclusive Collaboration in The Field Of Cell and Gene Therapy Manufacturing in Japan.
  Neostem Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma
  Combimatrix Launches Buccal Swab Dna Collection As Alternative To Blood Draws For Postnatal Genetic Testing
  New Ultra-Low Temperature Freezer Offers Outstanding Sustainability and Sample Protection
  Neostem, Inc and Allcells, Llc To Collaborate With Mount Sinai As Part Of $8.8 Million Grant To Further Stem Cell Research
  Sysmex Inostics Announces Agreement With Indivutest To Offer Blood Based Mutation Testing
  Celgene To Acquire Quanticel Pharmaceuticals
  Cord Blood Registry® Uses Biolife Solutions Cryostor® Clinical Grade Freeze Media in The Storage Of Umbilical Cord Tissue Stem Cells
  Florida Hospital Cancer Institute Selects Stemsoft Clinic
  Genmab Achieves Usd 10 Million Milestones in Daratumumab Collaboration With Janssen
  Alvetex® 3d Cell Culture Platform Reaches New Heights With Project Aboard The International Space Station (Iss).
  Lonza Introduces Cytosmart™ System For Walk-Away Live Cell Imaging
  Brooks Automation Introduces Biostore Iii Cryo Automated Cryogenic Sample Management System
  Biocision and Brooks Joint Development Partnership To Unveil New Cryogenic Sample Handling and Transport Product
  Paml and Bloodworks Nw Sign Letter Of Intent To Collaborate on Innovation
  Brooks Automation Introduces Biostore Iii Cryo Automated Cryogenic Sample Management System
  Biotime’s Clinical Grade Stem Cells From Subsidiary Es Cell International To Be Used in Planned Cirm-Funded Preclinical Studies Of Huntington’s Disease
  Biotime Licenses Beckman Research Institute Of City Of Hope To Manufacture Clinical Grade Stem Cells
  Blood Center Affiliation Unveils New Name, Expanded Offerings To Healthcare Systems
  Lonza Introduces Cytosmart™ System For Walk-Away Live Cell Imaging
  Fujifilm Holdings To Acquire Cellular Dynamics International, Inc.
  Genvec and Therabiologics Form Collaboration To Develop Neural Stem Cell Mediated Cancer Therapies
  Cryo-Cell International, Inc., Cord Blood Banking Leader, Takes Significant Ownership Stake in Cord Blood America, Inc., and Encourages Cbai Shareholders To Vote Against Upcoming Share Authorization Proposal
  Combimatrix Selects Cryoport As Logistics Partner For The Distribution Of Its New Genetic Screening Service
  Bluechiip Tracking Solutions Executing Strategic Priorities in Biobanking
  Cordlife Partners With Leading Neurologist on   Study in Child Autism Using Own Cord Blood Stem Cells
  Leica Em Cryo Clem Features The World’s First Cryo Clem Objective
  Partnership With Live Cell Imaging Company
  Astrazeneca To Collaborate With The Harvard Stem Cell Institute in Diabetes
  Handheld Wireless 1d / 2d Code Reader
  Biolife Solutions Cryostor® Cell Freeze Media Used in Mayo Clinic Safety and Feasibility Study Of Umbilical Cord Blood-Derived Cells For Pediatric Cardiac Regeneration
  Expiration Of The Option Of Teva Under The License Agreement With Cellcure Neurosciences
  University Of Illinois At Chicago Selects Stemsoft Clinic
  Esperite Pioneers First Treatment Worldwide Of Cerebral Palsy Using Two Types Of Stem Cells
  Greiner Bio-One Presents Innovative Cryo’s Biobanking Tubes
  Esi Bio – A Division Of Biotime, Inc., Announces Alliance Agreement With Pivotal Scientific Ltd For Distribution Of Stem Cell Products
  Puget Sound Blood Center Is Now Bloodworks Northwest
  Labcorp Completes Acquisition Of Covance
  Biolife Solutions Launches New Cell Thawing Media Products in Response To Worldwide Shortage Of Dextran Solutions
  Tigenix and Lonza Sign Agreement For The Manufacture Of Stem Cell-Based Treatment Of Complex Perianal Fistulas in Crohn’s Disease
  Epistem Announces The Successful Evaluation Of New Rna-Amp™ (Rna-Amplification) Technology
  Stemgent, A Reprocell Group Company and Transposagen Biopharmaceuticals Enter Into A Service Partnership Agreement Providing Genetically Engineered Stem Cells
  Tigenix and Lonza Sign Agreement For The Manufacture Of Stem Cell-Based Treatment Of Complex Perianal Fistulas in Crohn’s Disease
  International Stem Cell Corporation Announces Completion Of Cell Bank For Parkinson's Disease Clinical Trial
  Cellular Dynamics Manufactures Cgmp Hla “Superdonor” Stem Cell Lines To Enable Cell Therapy With Genetic Matching
  Vitro Biopharma Announces Advances in Clinical Application Of Stem Cell Therapy For Neurological Conditions
  New Healthy Ageing Biobank Milestone
  Alliqua Biomedical, Inc. To Acquire Celleration, Inc.
  Agilent Technologies Introduces Oneseq To Streamline Cytogenetic Research
  Cancercare Manitoba Selects Stemsoft Lab
  Alliqua Biomedical Announces Group Purchasing Agreement With Premier, Inc.
  Valeant and Astrazeneca To Partner on Brodalumab
  Harvard Bioscience Acquires All Operations Of Heka Electronik
  Brooks Automation Announces Collaboration Agreement With Chart Industries
  Avita Medical Announces First Patient Enrollment in Us Pivotal Study Of Recell® For The Treatment Of Burns
  Neostem Receives Drug Manufacture License For Irvine Facility
  Neostem and Invetech Announce Agreement To Develop Closed Processing System For Cell Therapy Manufacturing
  Cord Blood Registry and Cellular Dynamics International Announce Collaboration To Reprogram Newborn Stem Cells Into Induced Pluripotent Stem Cells
  Cord Blood Registry and China Cord Blood Corporation Enter Into Strategic Collaboration
  China Cord Blood Corporation and Cord Blood Registry Enter Into Strategic Collaboration
  Essential Pharmaceuticals Provides Solutions To Keep Cells and Organs Healthy
  Apollo Health and Lifestyle Ltd. Expands Its Footprint With The Acquisition Of Nova Specialty Hospitals
  Brooks Automation Announces Collaboration Agreement With Chart
  Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing
  Symphogen A/S Licenses The Selexis Suretechnology Expression Platform and Cell Line
  Nyscf and The Cmta Enter Collaboration To Advance Neuropathies Research
  Leica Biosystems and Mayo Clinic Collaborate on Future Of Cytogenetics Imaging
  Biotime Subsidiary Es Cell International and Ge Healthcare Cross-License Patents in The Field Of Cell Assays For Drug Testing
  Takara Bio Inc. Will Take Over The Supply Of Sc Proven Products Formerly Supplied By Stem Cells Sciences
  Mr Solutions Announces The First Installations Of Its Second Generation Cryogen Free Magnet Technology For Increased Scientific Capabilities in Preclinical Mri
  Geron Announces Early Hsr Clearance For Global Strategic Collaboration With Janssen
  Cryofab Inc. (Nj) Acquisition Of Leading Cryogenic Valves Suppliers Cryocomp Inc. (Ca)
  Novadaq Appointed Exclusive Worldwide Distributor Of Lifenet Health’s Dermacell Tissue Products
  Toshiba Corporation Selects Affymetrix Axiom Platform For Its Newly Launched Genotyping Service in Japan
  Bloodcenter To Form Strategic Alliance With Indiana Blood Center
  Cytomedix Announces Corporate Name Change To Nuo Therapeutics, Inc.
  Irvine Scientific Introduces Dmso-Free, Chemically-Defined Cryopreservation Solution For Mesenchymal Stem Cells
  Bluechiip Signs International Agreement For Technology Integration
  Sigma-Aldrich Completes Acquisition Of Cell Marque
  Cellular Dynamics and Northwestern University Take First Steps Toward Rebuilding An Organ Using Manufactured Human Cells
  Baker Ruskinn Brand Promises New Tools For Cell Science
  Lifecell Corporation and Novadaq Technologies Agree To Early Transition Of Spy Elite® Intraoperativeperfusion Assessment System Business Back To Novadaq.
  Affymetrix Exclusively Licenses Technology From Peptide Groove Llp For Hla Typing From Genotyping Data
  Alliqua Biomedical Announces Expansion To Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics
  New Blast Freezers Offer Rapid Freezing For Short and Long Term Cold Storage
  New Innovations Advance Upstream and Downstream Bioprocessing For Biopharmaceutical Manufacturers
  Osiris and Arthrex Announce An Exclusive Partnership For The Commercialization and Development Of Cartiform®
  Baker Introduces Cultivo™ Co2 Incubator
  Baker Ruskinn Brand Promises New Tools For Cell Science
  Brooks Automation Acquires Fluidx, A Leading Provider Of Consumables and Instruments Used For Biological Sample Storage
  Roslin Cells Working With Tokyo Electron on Developing New Smart Cell Processing Technologies
  Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank
  Roosterbio Selects Biolife Solutions Cryostor® To Commercialize Human Bone Marrow-Derived Stem Cells
  Reprocell Acquires The Ips Cell Business Unit Of Stemgent, Inc.
  Brainstorm Granted European Patent Covering Its Stem Cells For The Treatment Of Cns Diseases
  Biolife Solutions Forms Biologistex Ccmsm Joint Venture With Savsu® Technologies To Market Intelligent, Controlled Temperature Containers For Biologics
  Failure To Invest in Biobank ‘May Jeopardise Storage Of Vital Tissue Samples
  Labcorp Announces Agreement To Acquire Liposcience
  Irvine Scientific Introduces Serum-Free Differentiation Media To Its Cell Therapy Product Line
  Cryomagnetics Acquires R & D Tectonics
  Stem Cell Company Reprocell (Japan) Acquires 3d Cell Culture Company Reinnervate Ltd (Uk) and Human Tissue Supplier Bioserve (Usa)
  Fda Clears Mayo Clinic For Manufacture Of Nurown and Participation in Brainstorm’s Phase 2 Als Trial
  Vistagen Receives Notice Of Allowance For Canadian Patent Further Expanding Stem Cell Technology Platform
  Beckman Coulter Diagnostics and Copan Announce Expansion Of Distribution Agreement For Automated Sample Processing Systems and Digital Microbiology
  Biovision Introduces Industry's Most Simplified Cetp and Pltp Activity Assay Kits
  New Highly Sensitive Test To Screen Donors Of Blood, Tissues, and Organs For Hepatitis E Virus Receives Ce Mark
  Essential Pharmaceuticals Announces The Release Of Cell-Ess® Serum Replacement For Cell Culture
  Cellular Dynamics Awarded Patents Covering Derivation Of Pluripotent Stem Cells From Fresh Or Banked Human Blood Samples
  China Cord Blood Corporation and Cordlife Group Limitedannounce Collaboration To Aid Asia-Based Patientswith Cord Blood Stem Cell Therapy
  The Tecan Group (Six Swiss Exchange: Tecn) Today Announced The Acquisition Of Ibl International
  International Stem Cell Corporation Signs Agreement Including Certain Terms For A Definitive License Agreement With Rohto Pharmaceutical Co., Ltd. Of Japan
  Combimatrix Signs Contract With Stratose
  Cordlife Group Limited and China Cord Blood Corporation Announce Collaboration To Aid Asia-Based Patients With Cord Blood Stem Cell Therapy
  Lane Blood Center and Psbc Confirm Affiliation
  Precious Cells Biobank Acquires Stem Cell Technology Leader Pharmacells Group
  Biolife Solutions Announces Manufacturing Agreement With Somahlution Llc
  Geisinger and Indivumed Partner For Personalized Medicine Initiative in The USA
  Rutgers’ Human Genetics Institute Lab Expands Into Clinical Testing
  Cord Blood America, Inc. Announces Mesenchymal Stem Cell Expanded Tissue Service Offering Positions Company To Participate in One Of The Fastest Growing Areas Of Stem Cell Research
  Tecan Unveils New Fluent™ Laboratory Automation Solutions
  Atcc Teams With Cdc and Thermo Fisher Scientific on Public Health Rt-Pcr Assay
  Beaumont, Botsford, Oakwood Reach Definitive Agreement To Create New, Not-For-Profit Health Organization
  Partner With Flow Cytometers Analyzers Company
  Cell Therapeutics, Inc. Announces Change Of Name To Cti Biopharma Corp. Seattle
  Cryoxtract Announces Integration Of Cxt750 System Into France's National Institute For Agricultural Research For Use in Important Human Gut Microbiome Research
  Cryoxtract Enters Into Distribution Agreements With Cambridge Bioscience Ltd. and Lbd Life Sciences Ltd.
  Alliqua Acquires Choice Therapeutics
  Cellcentric Receives Patent Grants For Gene Demethylation Technology
  Partner With Time-Lapse Cytometers Company
  Cellular Dynamics Announces Launch Of Icell(R) Dopaneurons, Neural Floor Plate-Derived Midbrain Dopaminergic Neurons
  Brooks Automation, The University Of Oxford and Uk Biocentre Announce Purchase Of Multiple Brooks Automated Sample Management Systems
  Roslin Cells To Manufacture Blood Cultured From Stem Cells
  Neostem Announces Definitive Agreement To Acquire California Stem Cell, Inc.
  Atcc Expands Its Portfolio Of Certified Reference Materials To Include Quantitative Mycoplasma Dna
  Alliqua Biomedical, Inc. To Acquire Celleration, Inc.
  Lonza and Biowa Sign Potelligent® Chok1sv Cell Line Technology Licensing Agreement With Argen-X
  Combimatrix Announces Partnership With American Pathology Partners To Provide Products Of Conception Testing
  Takara Bio Obtains A Governmental Grant For Commercialization Of Its Tcr Gene Therapy Projects
  Brainstorm Granted Key Us Patent For Its Autologous Stem Cell Technology
  Lonza and Biowa Sign Potelligent® Chok1sv Cell Line Technology Licensing Agreement With Argen-X
  Modular Vertical Freezer Rack For Biobanking Launched By Micronic
  Greiner Bio-One Presents Innovative Cryo.S Biobanking Tubes
  Thermo Fisher Scientific Completes Acquisition Of Life Technologies Corporation
  Biopta Announces Launch Of Industry’s First Catalogue Of in Vitro Human Tissue Assays
  Thermo Fisher Scientific Reaches Agreement To Sell Its Cell Culture, Gene Modulation and Magnetic Beads Businesses To Ge Healthcare
  Biomatrica and Sigma-Aldrich Sign Distribution Agreement
  Athersys Announces New Patents in Japan For Stem Cell and Regenerative Medicine Technology
  Cell Therapy's Heart Tissue Regeneration Hope
  Cellular Dynamics Signs Agreement With Nestle Institute Of Health Sciences To Supply Icell® and Mycell® Products For Nutritional Research
  Lifecell Corporation Acquires Advanced Adipose Tissue Injector
  Combimatrix Announces Contract With Galaxy Health Network
  Combimatrix Announces Partnership With Propath To Provide Products Of Conception Testing
  Stemsoft Software Inc. and Jaf Consulting, Inc. Announce Collaborative Partnership
  Thermo Fisher Scientific Reaches Agreement To Sell Its Cell Culture, Gene Modulation and Magnetic Beads Businesses To Ge Healthcare
  New Dmso-Resistant 1536 Well Storage Plate
  Bmg Labtech and Invivosciences, Inc. Initiate Market Collaboration To Accelerate Drug Discovery in Engineered 3d Tissues
  Low Profile Screw Caps Designed in Conjunction With The Hannover Unified Biobank Launched By Micronic
  Queensland Node Of Apcb Gain Access To Unique Samples
  Thermo Fisher Scientific Brings Several Innovations in Bioprocessing Technologies and Systems
E. Market Trends
  Groundbreaking Technology Collaboration To Optimize Medical Research
  First 300 Cell Lines To Support Autism, Heart, Liver, Lung and Eye Disease Research
  Towards ‘Engagement 2.0’: Insights From A Study Of Dynamic Consent With Biobank Participants
  Finding Biomarkers For Early Lung Cancer Diagnosis
  Biobanking Viable Immune Cells - Transportation Matters!
  Cancer Biobank Informs Future Treatment
  World’s First T Cell-Qualified Serum Replacement Now Available
  Biobanking: A Vital Asset For Belgium Scientific Excellence
  Plasma Biobanking: Maximizing Patient Samples
  Bridging ‘Biobanking’ and Biomedical Research Across Europe and Africa: ‘B3africa’ Launched in Cape Town
  Finding The Best Way To Process Gut Microbiome Samples
  Innovation in Biobanking: Pushing The Boundaries
  New Research Tool Tracks Real-Time Dna-Protein Binding in Cells
  Seoulin Bioscience To Distribute Cellular Dynamics’ Products in Korea
  Cryogenic Storage Solution Available in Europe
  A Next-Gen Biobank That’s Based on The Cloud
  Health Research Group Makes Recommendations on Eu Data Protection Reforms
  Genotyping Begins on Nida’s Biorepository Of Over 50,000 Samples – Affymetrix, Biorealm, and Rucdr Infinite Biologics Team Up To Help Study The Genetics Of Addiction
  Reg-Galapagos Licenses Organoid Technology From The Hub Foundation For Use in Cystic Fibrosis and Ibd Research
  Ccfa Launches Development Of World’s Largest Research Database For Crohn’s Disease and Ulcerative Colitis
  The Joint Venture Of Synovial Tissue Cryopreservation
  Antifreeze Polymer Protects Cells As They Thaw
  Australia’s First Comprehensive Skin Cancer Tissue Bank
  Awareness Of The Procure Biobank
  Biosamples and Cryopreservation: What Tube Should I Use?
  Ibbl Teaches The Ins and Outs Of Biobanking
  Nhlbi Next Gen Consortium Partners With Wicell To Distribute Over 1,500 Well-Characterized, Novel Cell Lines For Use in Disease Research
  Automated Pbmc Isolation For Biobanking With Tecan’s Freedom Evo®
  Biotek Expands in The United Kingdom
  Ecacc and Ds Pharma – 10 Years Supporting Cell Culture Science in Japan
  Dried Blood Spots: New Applications For Biobanking?
  Multicare, Bloodworks Nw Expand South Sound Cord Blood Collection
  New Ultra-Low Temperature Freezer Offers Outstanding Sustainability and Sample Protection
  Biobanking For Global Prostate Cancer Research Collaboration
  The Uk Has Joined The Biobanking and Biomolecular Resources Research Infrastructure - European Research Infrastructure Consortium (Bbmr-Eric) At Its General Assembly
  Biobanking Collaboration For Lung Cancer Research
  Long-Term Biobanking: How Long Can You Hold Samples?
  Controlling Sample Exposure To Temperature Variability
  Thl Obtained Permission To Transfer Old Sample Collections To Thl Biobank
  Choosing Collection Kits Versus Bulk Supplies
  Future Of Biobanking and Translational Research in China
  Uw To Sell Patient Tissue Samples To Support Research
  Msc From Cord Tissue Used To Treat Graft-Versus-Host Disease
  First Patient Successfully Transplanted With Cryopreserved (Frozen) Nicord® in Gamida Cell’s Ongoing Phase I/Ii Clinical Trial For Blood Cancers
  Store For 20 Million Bio-Samples Opens in Milton Keynes
  Pass The Tissue: Ua Creates Bio Repository To Share With Competing Universities
  Cold Storage: Deep-Freeze Unit Is Vital To Oklahoma Medical Research Foundation's Work
  New European Storage Bank For Stem Cell Studies Coming To Babraham Research Campus
  Stem Cells: First Therapy Approved By Eu
  National Biobank Symposium Strengthens Cooperation in The Biobank Research
  From Dried Cod To Tissue Sample Preservation
  Hematologic Cancers: Umbilical Cord Transplantation
  New Method To Multiply Stem Cells Makes Cord Blood Even More Valuable
  Bioheart Announces Partnership in Colombia
  Survey Of Biobanks 2014 in Australia
  Biobanks Cooperation Will Bring Opportunities To The Individual Treatment Of Patients Published
  Luxembourg’s Biobank Collaborates With Us National Cancer Institute
  Ibbl Is Central Biobank For A New European Cancer Research Programme
  Cord Blood Cure For Autism
  Research That Explores The Use Of Umbilical Cord Blood Cells
  New Distribution Partner For Biotissue in Germany, Austria and Switzerland
  Research That Explores The Use Of Umbilical Cord Blood Cells
  Two New Chordoma Cell Lines Developed, Heading To Repository
  Valley Medical Center and Psbc Partner in Cord Blood Program
  Could Premature Babies Benefit From Their Own Cord Blood Stem Cells
  Nci Biobank Survey
  Thl Biobank in Finland Receives License To Operate
  Familycord Introduces Familycord Venezuela
  Plasticell Signs Deal With Jcr Pharmaceuticals To Use Combicult ® Stem Cell Technology in Japan
  Ebisc – The First European Bank For Induced Pluripotent Stem Cells
  Successful Release Of Sample To Treat Scid
  Wicell Expands Offerings For Researching Human Disease With Cell Lines Designed By Life Technologies For Fluorescent Protein Expression
  Biobanking From The Patient Perspective
  The Future Of Biobanking
  The Challenge: Recruit 500,000 Participants
  2015 Eu Data Protection Regulation – Impact on Research Updates
  Latest Cryo-Cell International Developments
  Cord Blood Stem Cells Can Treat Over 80 Life-Threatening Diseases
  Enriching Datasets Through Norwegian Biobank Data From Lifandis As and The Ims Pygargus Methodology
F. Key Company Profiles
  North America
  Europe
  Asia-Pacific
  Rest Of World
IV Industry Company Database
V. Appendix
  A. Research Focus
  B. About Axis Research Mind
  C. Disclaimer
  D. Feedback

List of Table

I. Report Focus
1. Compilation Of Studies Describing The Stability Of Specific Biomarkers For Biospecimens (Biofluids, Cells, Tissues) As A Function Of Storage Temperature/Duration
2. Storage Time, Number, Type Of Sample and Average Rin Values
3. Dna Samples and Their Source
4. A List Of Possible Pre-Analytical Variables That Could Affect Samples in A Cancer Biobank

J. Human Biobanking Applications - Geography Market Briefing
North America
5. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other For North America Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
6. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other - % Of North American Market Value - (2017-2020)

Europe
7. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other For Europe Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
8. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other - % Of European Market Value - (2017-2020)

Asia-Pacific
9. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other For Asia-Pacific Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
10. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other - % Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
11. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other For Rest Of World Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
12. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other - % Of Rest Of World Market Value - (2017-2020)

K. Human Biobanking Advanced Applications - Geography Market Briefing
North America
13. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics For North America Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
14. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics - % Of North American Market Value - (2017-2020)

Europe
15. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics For Europe Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
16. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics - % Of European Market Value - (2017-2020)

Asia-Pacific
17. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics For Asia-Pacific Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
18. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics - % Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
19. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics For Rest Of World Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
20. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics - % Of Rest Of World Market Value - (2017-2020)

II. Market Analysis
21. Global Human Biobanking - Segmentation By Application

Human Biobanking Application - Global
22. Human Biobanking Application Market - Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
23. Human Biobanking Application Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
24. Human Biobanking Application Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

Human Biobanking Application – By Geography
North America
25. Human Biobanking Application Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
26. Human Biobanking Application - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
27. Human Biobanking Application Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
28. Human Biobanking Application Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
29. Human Biobanking Application Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
30. Human Biobanking Application Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
31. Human Biobanking Application Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
32. Human Biobanking Application Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Human Biobanking - By Applications Type
33. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other For Global Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
34. Human Biobanking Application Market - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other - % Of Global Market Value - (2017-2020)

Human Biobanking Application - Type - By Geography
Stem Cells
35. Stem Cells Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
36. Stem Cells Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
37. Stem Cells Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
38. Stem Cells Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
39. Stem Cells Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
40. Stem Cells Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
41. Stem Cells Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
42. Stem Cells Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
43. Stem Cells Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
44. Stem Cells Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Advanced Application
45. Advanced Application Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
46. Advanced Application Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
47. Advanced Application Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
48. Advanced Application Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
49. Advanced Application Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
50. Advanced Application Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
51. Advanced Application Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
52. Advanced Application Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
53. Advanced Application Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
54. Advanced Application Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Advanced Application - By Type
55. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics For Global Current Trends, Estimates & Forecasts - (2014-2020, in Usd$ Million)
56. Advanced Application Market - Biomarkers, Drug Discovery, Genomics and Forensics - % Of Global Market Value - (2017-2020)
Advanced Application – Type – By Geography
Biomarkers
57. Biomarkers Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
58. Biomarkers Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
59. Biomarkers Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
60. Biomarkers Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
61. Biomarkers Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
62. Biomarkers Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
63. Biomarkers Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
64. Biomarkers Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
65. Biomarkers Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
66. Biomarkers Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Drug Discovery
67. Drug Discovery Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
68. Drug Discovery Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
69. Drug Discovery Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
70. Drug Discovery Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
71. Drug Discovery Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
72. Drug Discovery Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
73. Drug Discovery Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
74. Drug Discovery Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
75. Drug Discovery Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
76. Drug Discovery Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Genomics
77. Genomics Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
78. Genomics Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
79. Genomics Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
80. Genomics Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
81. Genomics Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
82. Genomics Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
83. Genomics Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
84. Genomics Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)
Rest Of World
85. Genomics Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
86. Genomics Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Forensics
87. Forensics Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
88. Forensics Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
89. Forensics Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
90. Forensics Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
91. Forensics Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
92. Forensics Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
93. Forensics Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
94. Forensics Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
95. Forensics Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
96. Forensics Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Blood and Blood Products
97. Blood and Blood Products Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
98. Blood and Blood Products Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
99. Blood and Blood Products Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
100. Blood and Blood Products Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
101. Blood and Blood Products Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
102. Blood and Blood Products Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
103. Blood and Blood Products Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
104. Blood and Blood Products Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
105. Blood and Blood Products Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
106. Blood and Blood Products Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Organs
107. Organs Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
108. Organs Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
109. Organs Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
110. Organs Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
111. Organs Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
112. Organs Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
113. Organs Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
114. Organs Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
115. Organs Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
116. Organs Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Research
117. Research Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
118. Research Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
119. Research Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
120. Research Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
121. Research Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
122. Research Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
123. Research Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
124. Research Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
125. Research Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
126. Research Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Pharmaceuticals
127. Pharmaceuticals Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
128. Pharmaceuticals Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
129. Pharmaceuticals Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
130. Pharmaceuticals Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
131. Pharmaceuticals Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
132. Pharmaceuticals Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
133. Pharmaceuticals Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
134. Pharmaceuticals Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
135. Pharmaceuticals Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
136. Pharmaceuticals Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

Other Human Biobanking Application
137. Other Human Biobanking Application Market - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific and Rest Of World - (2014-2020, in Usd$ Million)
138. Other Human Biobanking Application Market - % Of North America, Europe, Asia-Pacific and Rest Of World Market Value - (2017-2020)

North America
139. Other Human Biobanking Application Market - Usa, Canada and Mexico - (2014-2020, in Usd$ Million)
140. Other Human Biobanking Application Market - % Of Usa, Canada and Mexico Market Value - (2017-2020)

Europe
141. Other Human Biobanking Application Market - United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe - (2014-2020, in Usd$ Million)
142. Other Human Biobanking Application Market - % Of United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest Of Europe Market Value - (2017-2020)

Asia-Pacific
143. Other Human Biobanking Application Market - China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific - (2014-2020, in Usd$ Million)
144. Other Human Biobanking Application Market - % Of China, Japan, India, Australia, South Korea and Rest Of Asia-Pacific Market Value - (2017-2020)

Rest Of World
145. Other Human Biobanking Application Market - Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa - (2014-2020, in Usd$ Million)
146. Other Human Biobanking Application Market - % Of Brazil, Middle East, South Africa, Rest Of Latin America and Rest Of Africa Market Value - (2017-2020)

B. Growth Rate Analysis
147. Human Biobanking Application Market - Geographic Region - % Growth Rate Forecasts - (2014-2020)
148. Human Biobanking Application - Type - % Growth Rate Forecasts For Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other - (2014-2020)
149. Human Biobanking Advance Application - Type - % Growth Rate Forecasts For Biomarkers, Drug Discovery, Genomics and Forensics - (2014-2020)

C. Investment Focus
150. Human Biobanking Application - Forecasted Cagr% - 2014-2020 - Top 10 Countries - Usa, Germany, United Kingdom, Brazil, Spain, China, Japan, South Korea, South Africa and India
151. Human Biobanking Application - Type - Stem Cells, Advanced Application, Blood and Blood Products, Organs, Research, Pharmaceuticals and Other- Forecasted Cagr% - 2014-2020 - Top 10 Countries - Usa, Germany, United Kingdom, Brazil, Spain, China, Japan, South Korea, South Africa and India
152. Human Biobanking Advance Application - Type - Biomarkers, Drug Discovery, Genomics and Forensics- Forecasted Cagr% - 2014-2020 - Top 10 Countries - Usa, Germany, United Kingdom, Brazil, Spain, China, Japan, South Korea, South Africa and India

III. Industry Overview
153. Ccb Invention Of Methods For Data Sourcing Of Biological Samples To All Types Of Biobanks
154. Ccb Invention To Biobanks For Maintaining Minimum Standards
155. Ccb Invention To Biobanks For Best Practice Standards
156. Methods To Link / Delink Data / Samples With Their Identifiers
157. Worldwide Key Players Into Human Biobanking Industry That Project Improved Market Activities in The Near Future